Active	Status	Sponsor type	Region	Phase	Filter
9 Active 1 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hu, Bo
NCT05181475: Long-term Efficacy and Safety Study of GV-971	Active, not recruiting	4	800	RoW	Sodium Oligomannate Capsules (GV-971)	Green Valley (Shanghai) Pharmaceuticals Co., Ltd.	Alzheimer Disease	01/25	06/25
NCT04649242 / 2020-003517-35: Randomized Study in Children and Adolescents With Migraine: Acute Treatment	Recruiting	3	2100	Europe, Canada, Japan, US, RoW	Rimegepant/BHV3000, Matching placebo	Pfizer	Pediatric Migraine	01/29	01/29
NCT05811442: Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease	Recruiting	2a	60	RoW	50561 high dose, 50561 low dose, Placebo	Beijing Joekai Biotechnology LLC	Alzheimer's Disease	05/24	06/24
NCT06044350: A Clinical Trial of BAT4406F Injection in Patients with Neuromyelitis Optica Spectrum Disorders	Recruiting	2	162	RoW	BAT4406F Injection, BAT4406F Placebos	Bio-Thera Solutions	Optic Neuromyelitis Spectrum Disease	05/25	05/26